Sempre a proposito del CoVid-19..

A riprova di quanto ho scritto nell'articolo precedente, ecco di seguito un articolo recentissimo, da PubMed, sulla veridicità di quanto affermo circa il CD26 come recettore del nuovo Coronavirus.
Ora più che mai si avvalora il potenziale terapeutico dell'anti CD26 nella risoluzione dell'epidemia che sta dilagando in tutto il mondo, se assunto ai primi sintomi dell'infezione.

2020 Mar 17 eCollection 2020
Emerging WuHan (COVID-19) Coronavirus: Glycan Shield and Structure Prediction of Spike Glycoprotein and Its Interaction With Human CD26
Naveen Vankadari 1 , Jacqueline A Wilce 1

Abstract
The recent outbreak of pneumonia-causing COVID-19 in China is an urgent global public health issue with an increase in mortality and morbidity. Here we report our modelled homo-trimer structure of COVID-19 spike glycoprotein in both closed (ligand-free) and open (ligand-bound) conformation, which is involved in host cell adhesion. We also predict the unique N- and O-linked glycosylation sites of spike glycoprotein that distinguish it from the SARS and underlines shielding and camouflage of COVID-19 from the host the defence system. Furthermore, our study also highlights the key finding that the S1 domain of COVID-19 spike glycoprotein potentially interacts with the human CD26, a key immunoregulatory factor for hijacking and virulence. These findings accentuate the unique features of COVID-19 and assist in the development of new therapeutics.